IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q2 2020 Holdings

Filed 2020-08-13 | 3 holdings | $508.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$491.5K5,503,52896.6%
Epizyme, Inc.(EPZMEUR)COM29428V104$13.9K862,4022.7%
Acceleron Pharma Inc.(XLRN)COM00434H108$3.3K34,7840.7%